Semaglutide, initially developed as a treatment for blood sugar control, has proven significant recognition for its ability in encouraging body reduction. This injectable approach works by resembling a natural hormone that controls appetite and slows gastric processing, ultimately leading a lowering in food ingestion. While clinical trials have sho